bioAffinity Stock (NASDAQ:BIAF)
Previous Close
$1.69
52W Range
$1.25 - $46.53
50D Avg
$2.18
200D Avg
$7.90
Market Cap
$7.56M
Avg Vol (3M)
$2.90M
Beta
2.42
Div Yield
-
BIAF Company Profile
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
BIAF Performance
Peer Comparison
| Ticker | Company |
|---|---|
| PBM | Psyence Biomedical Ltd. |
| CARM | Carisma Therapeutics, Inc. |
| MNDR | Mobile-health Network Solutions Class A Ordinary Shares |
| WOK | WORK Medical Technology Group Ltd. |
| ARTL | Artelo Biosciences, Inc. |
| GTBP | GT Biopharma, Inc. |
| REVB | Revelation Biosciences, Inc. |
| SLRX | Salarius Pharmaceuticals, Inc. |
| PTIX | Protagenic Therapeutics, Inc. |